Watch the clinical case discussion by Prof. Dr. Paolo Gontero to learn more about the advantages of alternating cystoscopy with a urinary marker for the surveillance of intermediate-risk non-muscle-invasive bladder cancer (NMIBC).
Prof. Dr. Paolo Gontero is Professor of Urology at the University of Turin School of Medicine and Chairmen of the Division of Urology at the San Giovanni Battista (Molinette) Hospital, Italy.
He presents 2 clinical patient cases with intermediate-risk NMIBC (Bruce and Jonathan) for whom the use of a urinary biomarker could be safely implemented in the follow-up scheme to detect recurrences.